ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 95 filers reported holding ALBIREO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $186,127 | +17.8% | 8,613 | +5.4% | 0.00% | 0.0% |
| Q3 2022 | $158,000 | -1.2% | 8,171 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $160,000 | -36.0% | 8,055 | -3.8% | 0.00% | 0.0% |
| Q1 2022 | $250,000 | +19.6% | 8,377 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $209,000 | -27.4% | 8,966 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $288,000 | -13.5% | 9,235 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $333,000 | -4.3% | 9,454 | -4.2% | 0.00% | 0.0% |
| Q1 2021 | $348,000 | -5.7% | 9,872 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $369,000 | +39.2% | 9,846 | +23.8% | 0.00% | 0.0% |
| Q3 2020 | $265,000 | +23.3% | 7,953 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $215,000 | +73.4% | 8,133 | +7.7% | 0.00% | 0.0% |
| Q1 2020 | $124,000 | -28.3% | 7,554 | +10.9% | 0.00% | 0.0% |
| Q4 2019 | $173,000 | +26.3% | 6,814 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $137,000 | -35.4% | 6,871 | +4.6% | 0.00% | 0.0% |
| Q2 2019 | $212,000 | +13.4% | 6,566 | +13.1% | 0.00% | 0.0% |
| Q1 2019 | $187,000 | +27.2% | 5,808 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $147,000 | -26.1% | 5,996 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $199,000 | -5.7% | 6,043 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $211,000 | – | 5,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |